Join SwedenBio and PCG Clinical Services for a free lunch & seminar followed by a mingle on April 19th in Medicon Village, Lund. We are bringing together our experts in clinical drug development for a half day of learning. If you are a small biotech company and would like to learn more about how to navigate the transition from pre-clinical to clinical research & development then register below.
Reducing time and cost to market and increasing the chances of a drug’s success are essential for pharmaceutical companies of all sizes, but especially for small biotechs that may not have access to extensive capital. Asking the right questions is essential for small biotech companies approaching the clinical phase, that’s why our experts will address the whos, whats, whens, and hows of clinical research. The registration is now opened up, so make sure you sign up before our limited seating runs out.
April 19th, 2018
11:30 Registration and lunch
16:30 to 18:00 Mingle
Where: Venus Conf. room in Medicon Village
Learn about the speaker lineup:
Sverre Bengtsson Co-founder, Sr. VP, Strategic Relations, Chairman of the Board for the PCG group of companies.
Sverre Bengtsson is one of our Co-founders and has served as a member of our board of directors since our inception in March 2003. Sverre holds an MBA from the University of Gothenburg, Sweden, and has more than 20 years of experience in clinical research.
Bjorn Ursing Program Director at SwedenBIO and Nordic Life Science Days
Björn has an academic background as Assoc Prof at Karolinska Institutet and for the last 15 years had various positions in the life science industry.
Gunnar Danielsson Sr. Regulatory Advisor
Gunnar has a BSc in Natural Science and almost 40 years’ experience in Clinical Research. Gunnar served as a renowned GCP Inspector for the Swedish MPA for over 10 years, and has a wealth of experience from the Pharmaceutical industry in terms of quality management, electronic systems, data management, and clinical design and conduct. Gunnar is a key advisory resource and he helps to design studies in the most effective way, meeting regulatory requirements.
Sven Undeland, owner at FHC Undeland and partner at PCG Clinical Services
Sven has a broad commercial and clinical development experience from international pharmaceutical industry, based on leading positions in Pharmacia, AstraZeneca and Orexo. Sven’s strength is to give strategic commercial support in life science projects during development, to prepare the projects for successful licensing or launch. In addition, Sven has five years’ experience from business development and has successfully negotiated and completed several licensing deals. Sven has a Master in Science (M.Sc) in Chemical and Administrative Sciences.
Antonio Mastroianni, Business Developer at PCG Clinical Services
Antonio has 20 years of multi-sector experience in government, non-profit, standard-setting bodies, and for-profit organizations. Over the course of working with various organizations across the US and Europe Antonio has specialized in IT/Telecom management consulting and Healthcare. His primary focus today with PCG Clinical Service is in partnership management, business development, and transformation.